ARCHIVE

• JPMA Conducts Survey on Compliance with Promotion Code
  November 1, 2004

• Fuji Chemical Industry Develops New Filler for Orally Disintegrating Tablets
  November 1, 2004

• Novartis' Zometa Approved for Hypercalcemia due to Malignant Tumors
  November 1, 2004

• Standard Chemotherapy for NSCLC to Be Specified in GLs
  November 1, 2004

• Tsumura Sets Standards for Pesticide Residues in Crude Drugs
  November 1, 2004

• REGULATORY NEWS IN BRIEF
  November 1, 2004

• JPMA, FPMAJ Call For Preferential Tax System for Orphan Drugs
  November 1, 2004

• 35 Healthcare-related Bodies Rally against "Mixed Medical Care"
  November 1, 2004

• Wishing to Clarify Real Role of FPMAJ: Chairman Takeda
  November 1, 2004

• Korosho Study Group Prepares Package Inserts for Patients
  November 1, 2004

• DIAGNOSTIC NEWS IN BRIEF
  November 1, 2004

• Korosho Study Group on Vaccination Holds 1st Meeting
  November 1, 2004

• 55th WMA General Assembly
  October 25, 2004

• Necessary to Further Open the Way to Mixed Medical Care: Health Minister Otsuji
  October 25, 2004

• Ministries to Cooperate to Develop Nanotech in Healthcare Field
  October 25, 2004

• NER PRODUCTS
  October 25, 2004

• Continue to Grow Above Market Level: Mr Banchi of Boehringer Ingelheim
  October 25, 2004

• Council Insists on Lifting of Ban on "Mixed Medical Care"
  October 25, 2004

• Roche Eager to Strengthen Presence in Japan: Mr Noguchi
  October 25, 2004

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  October 25, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 502
• 503
• 504
• 505
• 506
• 507
• 508
• 509
• 510
• …
• Next ›
• 最終 »